All is well in the Magic Kingdom as�Disney’s�(NYSE:DIS) stock has surged since the beginning of the year��p almost 27 percent in the last six months. The mass media corporation reported impressive second quarter earnings back in May, with CEO Bob Iger citing ��he strength of [Disney��] brands and the value of high-quality creative content��as the main catalysts for long-term growth. As we enter into the second half of 2013, will Disney continue to beat the market or is its ��agical��ride over? Let�� use our CHEAT SHEET investment framework to decide whether Disney is an OUTPERFORM, WAIT AND SEE, or STAY AWAY.
C = Catalysts for the Stock’s Movement2012 was a year Disney’s studio entertainment division likely wishes to forget.�John Carter�was arguably the biggest flop in company history; however, operating income from the company’s third-largest division grew from $84 million in the red to $118 million in Q2 year-over-year — an increase of $202 million. Barring anymore tragedies like�John Carter,�the future looks bright for Disney’s studio entertainment division. First, Iron Man 3 has just surpased the $1 billion earnings mark, from which Disney should continue to enjoy revenues for the next couple quarters. Second, 2015 will be a huge year for Disney at the box office. Disney recently acquired Marvel and Lucasfilm, and thus, acquired the rights to the wildly popular�Star Wars�and�Avengers�films. With the expected releases of Star Wars 7�and�Avengers 2, as well as a�Finding Nemo�sequel in the works, Disney could see revenues of more than $2 billion from movies alone in 2015.
Top 5 Quality Stocks For 2015: THERMOGENESIS Corp.(KOOL)
ThermoGenesis Corp. designs, develops, and sells medical products that enable the practice of regenerative medicine worldwide. It offers automated and semi-automated devices, and single-use processing disposables that enable the collection, processing, and cryopreservation of stem cells and other cellular tissues used in the practice of regenerative medicine. Regenerative medicine is a field that uses cell-based therapies to repair or restore lost or damaged tissue and cell function. The company?s products include the AXP System, a medical device that isolates and retrieves stem cells from umbilical cord blood; the BioArchive System, a robotic cryogenic medical device used by cord blood banks for the cryopreservation and archiving of cord blood stem cell units for transplant; the MarrowXpress or MXP System that isolates and concentrates stem cells from bone marrow; Res-Q 60 BMC, a point-of-care bone marrow stem cell processing system; and Res-Q 60 PRP, which is used for t he preparation of autologous platelet rich plasma from a sample of blood at the point of care. It also offers ThermoLine product line, which includes ultra-rapid plasma ThermoLine Freezer and ultra-rapid plasma ThermoLine Thawer; and CryoSeal System, an automated system, which is used to prepare an autologous hemostatic surgical sealant. ThermoGenesis Corp. was founded in 1986 and is based in Rancho Cordova, California.
Advisors' Opinion:- [By John Udovich]
The controversy over stem cell research or their usage seems to have ebbed in recent years as stem cell science moves beyond the use of embryos and lately there has been a steady flow of overlooked good news from the sector or from small cap stem cell stocks like Cellular Dynamics (which will IPO soon), ThermoGenesis Corp (NASDAQ: KOOL) and BioRestorative Therapies (OTCBB: BRTX) for investors to digest. Just consider the following news:
- [By Monica Gerson]
ThermoGenesis (NASDAQ: KOOL) moved up 29.81% to $2.9857. ThermoGenesis' trailing-twelve-month revenue is $17.49 million.
Infosonics (NASDAQ: IFON) shares jumped 22.64% to $2.06. Infosonics shares have jumped 170.97% over the past 52 weeks, while the S&P 500 index has gained 23.35% in the same period.
Top 5 Quality Stocks For 2015: Boston Therapeutics Inc (BTHE)
Boston Therapeutics, Inc. is a development-stage company. The Company�� business is the development, manufacture and commercialization of therapeutic drugs and dietary supplements with a focus on glyco-pathology, a specialized field involving understanding the importance of carbohydrates in biochemistry and progression of diseases. The Company is focusing on three products: IPOXYN, an injectable anti-hypoxia drug, which it is developing; PAZ320, which is a non-systemic, chewable drug candidate for reduction of blood glucose in diabetics in development and SUGARDOWN, a complex carbohydrate-based chewable dietary supplement, which it is marketing. The Company�� non-systemic compounds for prediabetes and diabetes, SUGARDOWN and PAZ320, belong to the class of carbohydrate-hydrolyzing enzyme inhibitors.
SUGARDOWN
The Company has developed SUGARDOWN, a non-systemic complex carbohydrate-based dietary supplement to moderate post-meal blood glucose using processes and technology. It has unrestricted access to both sufficient raw materials at commodity pricing and processing facilities to produce sufficient supply of SUGARDOWN to support product distribution across multiple sales channels as a dietary supplement. Its SUGARDOWN dietary supplement consists of a stabilized complex carbohydrate composition. The Company has completed development of SUGARDOWN as a dietary supplement. On January 24, 2012 the Company announced the clinical trial results in healthy volunteers performed at the University of Sydney on SUGARDOWN.
PAZ320
PAZ320 is a non-systemic, non-toxic, chewable drug candidate for prevention of diabetes and its complications. PAZ320 inhibits the enzymes, which release glucose from complex carbohydrate in foods during digestion, reducing the amount of available glucose absorbed through the intestine. PAZ320 is in development as a drug candidate. The Company�� non-systemic compounds for prediabetes and diabetes, SUGARDOWN and PAZ320, belong to the! class of carbohydrate-hydrolyzing enzyme inhibitors.
IPOXYN
The Company has developed a drug candidate product IPOXYN, a glyco-protein based therapeutic agent. Its IPOXYN anti-hypoxia drug consists of a stabilized glycoprotein composition containing oxygen-rechargeable iron, targeting both human and animal tissues and organ systems deprived of oxygen and in need of metabolic support. In addition to potential uses for human patients, it also focuses to file a registration for IPOXYN for veterinary applications under the name OXYFEX. The Company�� pharmaceutical agents are intended for intravenous administration into the circulatory system to target acute and late stage diseases.
Advisors' Opinion:- [By CRWE]
Today, BTHE remains (0.00%) +0.000 at $1.10 thus far (ref. google finance Delayed: 12:25PM EDT October 10, 2013).
Boston Therapeutics has previously closed the final tranche of approximately $1.8 million to bring total gross proceeds of approximately $5.3 million from the private placement of Common Stock and warrants to existing and new accredited investors (the “Offering”).
Proceeds of the offering will be used to fund additional clinical trials for PAZ320, a non-systemic chewable drug designed to reduce the elevation of postprandial glucose or post-meal blood sugar for treatment of patients with Type 2 diabetes, and for general corporate purposes. PAZ320 is the first compound in a new class of therapies for this disease.
Top 5 Chemical Companies To Own In Right Now: Ryman Hospitality Properties Inc (RHP)
Ryman Hospitality Properties, Inc. (Ryman), incorporated on June 21, 2012, is a real estate investment trust (REIT). The Company�� segments consist of Hospitality, which include its hotel properties and the results of hotel operations, and Opry and Attractions, which includes its Grand Ole Opry assets, WSM-AM and its Nashville attractions. During the year ended December 31, 2012, Ryman�� owned assets included a network of four upscale, meetings-focused resorts totaling 7,795 rooms that were managed by lodging operator Marriott International, Inc. (Marriott) under the Gaylord Hotels brand. These four resorts, Gaylord Hotels properties, consist of the Gaylord Opryland Resort & Convention Center in Nashville, Tennessee (Gaylord Opryland), the Gaylord Palms Resort & Convention Center near Orlando, Florida (Gaylord Palms), the Gaylord Texan Resort & Convention Center near Dallas, Texas (Gaylord Texan) and the Gaylord National Resort & Convention Center near Washington D.C. (Gaylord National). Other owned assets managed by Marriott include Gaylord Springs Golf Links (Gaylord Springs), the Wildhorse Saloon, the General Jackson Showboat (General Jackson) and the Inn at Opryland, a 303-room overflow hotel adjacent to Gaylord Opryland. It also owns and operates a ranger of media and entertainment assets, including the Grand Ole Opry, the weekly showcase of country music�� performers for nearly 90 years; the Ryman Auditorium, the storied former home of the Grand Ole Opry located in downtown Nashville; and WSM-AM, the Opry�� radio home.
Gaylord Opryland Resort and Convention Center - Nashville, Tennessee
Gaylord Opryland is a convention destinations in the United States based upon number of rooms, exhibit space and conventions held. Designed with gardens and expansive atrium areas, the resort is situated on approximately 172 acres in the Opryland complex. As of Gaylord Opryland has a range of themed restaurants, retail outlets, and a full-service spa with 27,000 square feet of sp! ace and 12 treatment rooms. It also serves as a destination resort for vacationers due to its proximity to the Grand Ole Opry, the General Jackson Showboat, the Gaylord Springs Golf Links (Gaylord�� 18-hole championship golf course), and other attractions in the Nashville area. Gaylord Opryland has 2,882 signature guest rooms, four ballrooms with approximately 127,000 square feet, 111 banquet/meeting rooms, and total meeting, exhibit and pre-function space of approximately 640,000 square feet.
Gaylord Palms Resort and Convention Center - Kissimmee, Florida
During 2012, Gaylord Palms had 1,406 signature guest rooms, three ballrooms with approximately 76,000 square feet, 76 banquet/meeting rooms, and total meeting, exhibit and pre-function space of approximately 400,000 square feet. The resort is situated on a 65-acre site in Osceola County, Florida. Gaylord Palms has a range of themed restaurants, retail outlets and a full-service spa, with 20,000 square feet of dedicated space and 25 treatment rooms. It also has a resort pool and a 2-story sports bar complex opened at Gaylord Palms. Hotel guests also have golf privileges at Falcon�� Fire Golf Club.
Gaylord Texan Resort and Convention Center - Grapevine, Texas
Gaylord Texan is situated on approximately 85 acres and is located approximately six minutes from the Dallas/Fort Worth International Airport. The hotel features an expansive atrium, 1,511 signature guest rooms, three ballrooms with approximately 85,000 square feet, 70 banquet/meeting rooms, and total meeting, exhibit and pre-function space of approximately 400,000 square feet. The property also includes a range of themed restaurants, retail outlets and a full-service spa with 25,000 square feet of dedicated space and 12 treatment rooms. Guests also have access to the adjacent Cowboys Golf Club. The Company has Glass Cactus entertainment complex, an approximately 39,000 square feet venue with a performance stage, dance floor, and a two-story! outdoor ! deck, on land we own adjacent to the hotel.
Gaylord National Resort and Convention Center - National Harbor, Maryland
Gaylord National is situated on approximately 42 acres of land located on the Potomac River in Prince George�� County, Maryland, eight miles south of Washington. During 2012, the hotel had 1,996 signature guest rooms, four ballrooms with approximately 103,000 square feet, 82 conference and breakout rooms, and total meeting, exhibit and pre-function space of approximately 470,000 square feet. The hotel complex includes an 18-story glass atrium, a 20,000 square foot spa and fitness center with 12 treatment rooms, and entertainment options, such as restaurants, shops, and a two-story rooftop nightclub.
Inn at Opryland
The Company also owns the Inn at Opryland, which is located across the street from Gaylord Opryland. During 2012, the hotel had 303 rooms and approximately 14,000 square feet of meeting space.
The Grand Ole Opry
The Grand Ole Opry is a platform for country music. The Opry features a live country music show with performances every Friday and Saturday night, as well as additional weekly performances on a seasonal basis. The Opry House, home of the Grand Ole Opry, seats approximately 4,400 and is located in the Opryland complex. Each week, the Grand Ole Opry is broadcast live to millions of country lifestyle consumers on radio via WSM-AM and Sirius/XM Radio and streamed on the Internet. Special episodes of the Grand Ole Opry are also broadcast on television via the Great American Country network. The show has been broadcast since 1925 on WSM-AM, making it the longest running live radio program in the United States. In addition to performances by its members, the Grand Ole Opry presents performances by many other country music artists.
Ryman Auditorium
The Ryman Auditorium is designated as a National Historic Landmark. The former home of the Grand Ole Opry, the Ryman Auditor! ium re-op! ened for concerts and musical productions.
The General Jackson Showboat
The Company owns the General Jackson Showboat, a 300-foot, four-deck paddle wheel showboat, on the Cumberland River, which flows past the Gaylord Opryland complex in Nashville. Its Victorian Theatre can seat 600 people for banquets and 1,000 people for theater-style presentations. The showboat stages Broadway-style shows and other theatrical productions. The General Jackson is one of many sources of entertainment that is available to conventions held at Gaylord Opryland. During the day, it operates cruises, primarily serving tourists visiting the Gaylord Opryland complex and the Nashville area.
Gaylord Springs
Gaylord Springs consists of 40,000 square-foot antebellum-style clubhouse offers meeting space for up to 500 guests. Marriott assumed the management of the day-to-day operations of Gaylord Springs.
The Wildhorse Saloon
The Company has owned the Wildhorse Saloon, a country music performance venue on Second Avenue in downtown Nashville. The three-story facility includes a dance floor of approximately 2,000 square feet, as well as a restaurant and banquet facility that can accommodate up to 2,000 guests.
WSM-AM
WSM-AM is broadcast from the Gaylord Opryland complex in Nashville and has a country music format. WSM-AM station�� signal transmits 50,000 watt transmitter.
Advisors' Opinion:- [By Jim Royal]
The latest buy for my Special Situations portfolio is Ryman Hospitality (NYSE: RHP ) . The company operates four of the top 10 largest convention hotels in the U.S., and it converted to a REIT late last year, making it more likely to trade for a higher multiple. In March, I bought $2,000 of the stock, and it has since done little but go down. But Ryman is a solid company with premier properties that deserves to trade at a premium to peers, rather than a steep discount. So I'm adding another $1,000 to my position.
Top 5 Quality Stocks For 2015: BPZ Resources Inc (BPZ)
BPZ Resources, Inc., together with its subsidiaries, focuses on the exploration, development, and production of oil and natural gas in Peru and Ecuador. It owns rights and license agreements for oil and gas exploration and production covering approximately 2.2 million acres in 4 blocks in northwest Peru and off the northwest coast of Peru in the Gulf of Guayaquil. The company also owns a 10% non-operating net profits interest in an oil and gas producing property located in the southwest region of Ecuador. As of December 31, 2011, it had estimated net proved oil reserves of 34.7 million barrels (MMBbls) of crude oil or other liquid hydrocarbons, including 27.8 MMBbls were in the Corvina field and 6.9 MMBbls were from the Albacora field located in northwest Peru. The company was founded in 2001 and is headquartered in Houston, Texas.
Advisors' Opinion:- [By Lee Jackson]
BPZ�Resources Inc. (NYSE: BPZ) may be a small cap investor’s dream stock to buy. Its first well drilled�in the Corvina�field since 2010 was spudded in late July and likely will take about 12 weeks. It will take another week or so to achieve a stabilized flow rate before results are reported to the market, which means it will not expect to hear anything until November. The Raymond James price target for the stock is $4.50, the same as the consensus target.
Top 5 Quality Stocks For 2015: The Medicines Company(MDCO)
The Medicines Company, a pharmaceutical company, provides various medicines to hospitals for advancing the treatment of critical care patients worldwide. The company markets Angiomax, an intravenous direct thrombin inhibitor for use as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty and for use in patients undergoing percutaneous coronary intervention; and Cleviprex, an intravenous small molecule calcium channel blocker for the reduction of blood pressure, as well as to treat neurocritical care and cardiac surgery patients. Its products under development include Cangrelor that is in Phase III clinical trial acts as an intravenous small molecule antiplatelet agent to prevent platelet activation and aggregation; and Oritavancin, which is in Phase III clinical trial acts as an investigational intravenous antibiotic for the treatment of serious gram-positive bacterial infections, including acute bacterial skin and skin structure infections. The company?s products under development also comprise MDCO-157, a pre-registration stage product for platelet inhibition in patients suffering from acute coronary syndrome (ACS), and patients experiencing myocardial infarction, stroke, or peripheral arterial disease; MDCO-2010, a small molecule serine protease inhibitor that is in Phase II clinical trial used for the reduction of blood loss during surgery; and MDCO-216, which is in Phase I clinical trial used for the reversal of atherosclerotic plaque development and the reduction of the risk of coronary events in patients with ACS. Its products also consist of Argatroban, a direct thrombin inhibitor used as anticoagulant for prophylaxis or for the treatment of thrombosis; and acute care generic products. The Medicines Company was founded in 1996 and is based in Parsippany, New Jersey.
Advisors' Opinion:- [By Rich Duprey]
If all goes well in phase 3�trials for�ProFibrix's lead biologic, Fibrocaps -- a treatment�to stop bleeding during surgery -- shareholders of the Netherlands-based drugmaker could receive a hefty payday from The Medicines Company (NASDAQ: MDCO ) , which says it's willing to buy out the company if it can expect to bring the therapy to market here at home as well as in Europe.
- [By Lisa Levin]
The Medicines Company (NASDAQ: MDCO) shares touched a new 52-week low of $24.17 after the company provided an update on Angiomax patent litigation.
No comments:
Post a Comment